tuftsin has been researched along with Fibrosarcoma in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Catane, R; Fridkin, M; Fuks, Z; Gottlieb, P; Penchas, S; Schlanger, S; Treves, AJ; Weiss, L | 1 |
Babcock, GF; Banks, RA; Kazazi, F; Nishioka, K | 1 |
1 trial(s) available for tuftsin and Fibrosarcoma
Article | Year |
---|---|
Toxicology and antitumor activity of tuftsin.
Topics: Adult; Aged; Aging; Animals; Clinical Trials as Topic; Cytotoxicity, Immunologic; Dogs; Female; Fibrosarcoma; Humans; Lethal Dose 50; Leukocyte Count; Leukocytosis; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Middle Aged; Neoplasm Transplantation; Neoplasms; Spleen; T-Lymphocytes, Cytotoxic; Tuftsin | 1983 |
1 other study(ies) available for tuftsin and Fibrosarcoma
Article | Year |
---|---|
Effect of tuftsin on in vivo development of 3-methylcholanthrene-induced primary fibrosarcoma and Lewis lung carcinoma in mice.
Topics: Animals; Carcinoma; Cell Line; Fibrosarcoma; Lung Neoplasms; Methylcholanthrene; Mice; Mice, Inbred C57BL; Tuftsin | 1985 |